arrow
I

Iván Márquez-Rodas

university of medicine & pharmacy of craiova
H指数:40
被引数:2.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Title: Characterization of Melanoma of Unknown Primary in the Era of Immunotherapy and Targeted Therapy in Spain: Results from the Prospective Real World Study GEM 1801

标题:西班牙免疫治疗和靶向治疗时代未知原发灶黑色素瘤的特征:前瞻性真实世界研究GEM 1801的结果

2025-12-200
PRE
Antitumor activity of the combination of vinorelbine and gemcitabine in patients with HR + /HER2- advanced breast cancer after CDK4/6 inhibitor

CDK4/6抑制剂治疗后,长春瑞滨与吉西他滨联合方案在HR + /HER2-晚期乳腺癌患者中的抗肿瘤活性

2025-12-050
PRE
Treatment outcomes in patients with advanced mucosal melanoma in Spain: results from the real-world GEM1801 study

西班牙晚期黏膜黑色素瘤患者的治疗效果:来自真实世界GEM1801研究的结果

2025-12-010
PRE
Response rate and long-term survival in patients with advanced melanoma: data from the prospective cohort study gem-1801

应答率和长期生存率在晚期黑色素瘤患者中的表现:来自前瞻性队列研究gem-1801的数据

2025-11-280
OAAI
Author Correction: Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy

作者更正: 预防性TNF阻断在双重CTLA-4和PD-1免疫疗法中的功效和毒性

Nature
IF48.5
2025-10-010
OAAI
Nivolumab for Resected Stage III or IV Melanoma at 9 Years

纳武利尤单抗治疗已切除III期或IV期黑色素瘤9年结果

2025-10-015
PRE
Poor efficacy of anti PD-1 antibody based immunotherapy in patients with acral melanoma: results from the Spanish Melanoma Group (GEM) registry

肢端黑色素瘤患者中基于抗PD-1抗体免疫疗法的效果不佳:西班牙黑色素瘤组(GEM)登记研究的结果

2025-08-210
PRE
Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP-005 study recurrent glioblastoma cohort

伦伐替尼联合帕博利珠单抗用于先前接受过治疗的特定实体瘤患者:来自LEAP-005研究复发胶质母细胞瘤队列的2期研究结果

Cancer
IF5.1
2025-08-130
OAAI
Retreatment and rechallenge with BRAF/MEK inhibitors in patients with metastatic melanoma: results from the real-world Spanish Melanoma Registry (GEM-1801)

复发治疗和再挑战使用BRAF/MEK抑制剂在转移性黑色素瘤患者中的效果:来自西班牙黑色素瘤登记系统(GEM-1801)的真实世界结果

2025-07-270
PRE
An update on access to novel treatment for metastatic melanoma in Europe - A 2024 survey of the European melanoma registry and the European association of dermato-oncology

关于欧洲转移性黑色素瘤新型治疗方法可及性的最新进展——2024年欧洲黑色素瘤登记系统与欧洲皮肤肿瘤学会联合调查

2025-02-011
PRE
Challenges and perspectives in the management of BRAF-mutated metastatic melanoma: Systemic treatment sequencing and brain metastases

BRAF突变转移性黑色素瘤管理中的挑战与展望:系统治疗顺序与脑转移

2025-02-010
OAAI
10-y survival outcomes from the phase III CheckMate 067 trial of nivolumab plus ipilimumab in advanced melanoma

CheckMate 067试验中,纳武利尤单抗联合伊匹木单抗治疗晚期黑色素瘤的10年生存结局

2024-09-012
PRE
Encorafenib and binimetinib followed by radiotherapy for patients with BRAFV600-mutant melanoma and brain metastases (E-BRAIN/GEM1802 phase II study)

恩科非尼和比尼美替尼联合放疗治疗BRAFV600-mutant黑色素瘤和脑转移患者 (e-brain/GEM1802 II期研究)

2024-07-010
OAAI
Germline genetic testing before formal counseling: Impact in cancer management in a Spanish university hospital
2023-10-010
OAAI